共 27 条
- [23] PROCEDURAL AND 6-MONTH CLINICAL OUTCOMES OF CORONARY BIFURCATION LESIONS TREATED WITH THE NOVEL POLYMER-FREE DEDICATED BIFURCATION PACLITAXEL-ELUTING STENT (NILE PAX): RESULTS OF THE PROSPECTIVE, MULTICENTER BIPAX CLINICAL TRIAL JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1655 - E1655
- [24] A Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zotarolimus- vs. Paclitaxel-Eluting Stents in De Novo Occlusive Lesions in Coronary Arteries: Five-Year Results From the ZOMAXX I Trial CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (07) : 1039 - 1047
- [25] Six-Month Results of the NEVO RES-ELUTION I (NEVO RES-I) Trial A Randomized, Multicenter Comparison of the NEVO Sirolimus-Eluting Coronary Stent With the TAXUS Liberte Paclitaxel-Eluting Stent in De Novo Native Coronary Artery Lesions CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (06) : 556 - 564
- [26] Six-Month Results of the NEVO RES-ELUTION I (NEVO RES-I) Trial: A Randomized, Multicenter Comparison of the NEVO Sirolimus-Eluting Coronary Stent With the TAXUS Liberte Paclitaxel-Eluting Stent in De Novo Native Coronary Artery Lesions (vol 3, pg 556, 2010) CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (01) : E4 - E4
- [27] I-LOVE-IT - A Prospective, Multicenter Clinical Trial of TIVOLI Bioabsorbable Polymer Based Sirolimus-Eluting vs. ENDEAVOR Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease: 8-Month Angiographic and 1-Year Clinical Follow-Up Results AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 152D - 152D